Animal pain and distress in vaccine testing in the United States.

Martin L Stephens, G. M. Alvino, J. B. Branson

Research output: Contribution to journalArticle

Abstract

National statistics on animal use in research can provide guidance in setting priorities for research into alternative methods, i.e., those methods that can replace, reduce, or refine animal-based procedures. All else being equal, fields of research causing the most suffering to the largest numbers of animals should be considered prime candidates for alternative research. We examined national statistics on animal use in research in the United States to determine the extent to which vaccine testing accounts for those animals that experience unrelieved pain and distress. During 1998, 96,536 regulated animals were reported to have experienced unrelieved pain and distress in research (laboratory-bred mice and rats, as well as all non-mammals, are excluded from the U.S. reporting system). Vaccine-related testing alone accounted for 61% of this total. Of the 58,820 animals used in such vaccine testing, nearly all were hamsters (68%) and guinea pigs (28%), at least 74% were used in potency tests, and at least 55% were used in testing of Leptospira vaccine. This analysis and an earlier one both underscore the need to develop and implement alternative methods in vaccine testing.

Original languageEnglish (US)
Pages (from-to)213-216
Number of pages4
JournalDevelopments in Biologicals
Volume111
StatePublished - 2002
Externally publishedYes

Fingerprint

Vaccines
Animals
Pain
Testing
Research
Statistics
Leptospira
Research laboratories
Cricetinae
Rats
Guinea Pigs

ASJC Scopus subject areas

  • Drug Discovery
  • Immunology and Microbiology(all)
  • Public Health, Environmental and Occupational Health

Cite this

Animal pain and distress in vaccine testing in the United States. / Stephens, Martin L; Alvino, G. M.; Branson, J. B.

In: Developments in Biologicals, Vol. 111, 2002, p. 213-216.

Research output: Contribution to journalArticle

@article{3e7323836ea7464bb26d8d84552ffdb7,
title = "Animal pain and distress in vaccine testing in the United States.",
abstract = "National statistics on animal use in research can provide guidance in setting priorities for research into alternative methods, i.e., those methods that can replace, reduce, or refine animal-based procedures. All else being equal, fields of research causing the most suffering to the largest numbers of animals should be considered prime candidates for alternative research. We examined national statistics on animal use in research in the United States to determine the extent to which vaccine testing accounts for those animals that experience unrelieved pain and distress. During 1998, 96,536 regulated animals were reported to have experienced unrelieved pain and distress in research (laboratory-bred mice and rats, as well as all non-mammals, are excluded from the U.S. reporting system). Vaccine-related testing alone accounted for 61{\%} of this total. Of the 58,820 animals used in such vaccine testing, nearly all were hamsters (68{\%}) and guinea pigs (28{\%}), at least 74{\%} were used in potency tests, and at least 55{\%} were used in testing of Leptospira vaccine. This analysis and an earlier one both underscore the need to develop and implement alternative methods in vaccine testing.",
author = "Stephens, {Martin L} and Alvino, {G. M.} and Branson, {J. B.}",
year = "2002",
language = "English (US)",
volume = "111",
pages = "213--216",
journal = "Developments in Biologicals",
issn = "1424-6074",
publisher = "S. Karger AG",

}

TY - JOUR

T1 - Animal pain and distress in vaccine testing in the United States.

AU - Stephens, Martin L

AU - Alvino, G. M.

AU - Branson, J. B.

PY - 2002

Y1 - 2002

N2 - National statistics on animal use in research can provide guidance in setting priorities for research into alternative methods, i.e., those methods that can replace, reduce, or refine animal-based procedures. All else being equal, fields of research causing the most suffering to the largest numbers of animals should be considered prime candidates for alternative research. We examined national statistics on animal use in research in the United States to determine the extent to which vaccine testing accounts for those animals that experience unrelieved pain and distress. During 1998, 96,536 regulated animals were reported to have experienced unrelieved pain and distress in research (laboratory-bred mice and rats, as well as all non-mammals, are excluded from the U.S. reporting system). Vaccine-related testing alone accounted for 61% of this total. Of the 58,820 animals used in such vaccine testing, nearly all were hamsters (68%) and guinea pigs (28%), at least 74% were used in potency tests, and at least 55% were used in testing of Leptospira vaccine. This analysis and an earlier one both underscore the need to develop and implement alternative methods in vaccine testing.

AB - National statistics on animal use in research can provide guidance in setting priorities for research into alternative methods, i.e., those methods that can replace, reduce, or refine animal-based procedures. All else being equal, fields of research causing the most suffering to the largest numbers of animals should be considered prime candidates for alternative research. We examined national statistics on animal use in research in the United States to determine the extent to which vaccine testing accounts for those animals that experience unrelieved pain and distress. During 1998, 96,536 regulated animals were reported to have experienced unrelieved pain and distress in research (laboratory-bred mice and rats, as well as all non-mammals, are excluded from the U.S. reporting system). Vaccine-related testing alone accounted for 61% of this total. Of the 58,820 animals used in such vaccine testing, nearly all were hamsters (68%) and guinea pigs (28%), at least 74% were used in potency tests, and at least 55% were used in testing of Leptospira vaccine. This analysis and an earlier one both underscore the need to develop and implement alternative methods in vaccine testing.

UR - http://www.scopus.com/inward/record.url?scp=0037969698&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037969698&partnerID=8YFLogxK

M3 - Article

VL - 111

SP - 213

EP - 216

JO - Developments in Biologicals

JF - Developments in Biologicals

SN - 1424-6074

ER -